Abstract:Background: The Ki-67 proliferation index (PI) reflects the proliferation of cells. However, the conventional methods for the acquisition of the Ki-67 PI, such as surgery and biopsy, are generally invasive. This study investigated a potential noninvasive method of predicting the Ki-67 PI in patients with lung adenocarcinoma presenting with subsolid nodules. Methods: This retrospective study enrolled 153 patients who presented with pulmonary adenocarcinoma appearing as subsolid nodules (SSNs) on computed tomography (CT) images between January 2015 and December 2018. Presence of LUAD with SSNs was confirmed by histopathology. Of these participants, 107 patients were from institution 1 and were divided into a training cohort and an internal validation cohort in a 7:3 ratio. The other 46 patients were from institution 2 and were enrolled as an external validation cohort. All patients underwent conventional CT scans with thin-slice (<= 1.25 mm) reconstruction, and 1,316 quantitative radiomic features were extracted from the CT images for each nodule. The minimum redundancy maximum relevance and the least absolute shrinkage and selection operator were used for feature selection, and the radiomics signature was constructed based on these selected features. Clinical features were examined using univariate logistic regression analysis. The nomogram was developed based on the radiomics signature and the independent clinical risk factors. The Delong test and t test were employed for statistical analysis. The performance of different models was assessed by the receiver operating characteristic (ROC) curve. Results: The diameter of the nodules [odds ratio (OR) =1.17; P=0.003] was identified as an independent predictive parameter. Both the radiomics signature and the nomogram suggested a good predictive probability for Ki-67 expression. For the radiomics signature, the area under the ROC curve (AUC) for the training cohort, the internal validation cohort, and the external validation cohort was 0.86 [95% confidence interval (CI): 0.77 to 0.95], 0.81 (95% CI: 0.64 to 0.98), and 0.77 (95% CI: 0.62 to 0.91), respectively. For the nomogram, the AUC for the training cohort, the internal validation cohort, and the external validation cohort was 0.86 (95% CI: 0.77 to 0.95), 0.80 (95% CI: 0.64 to 0.97), and 0.79 (95% CI: 0.65 to 0.94), respectively. There were no statistical differences in the AUCs between the radiomics signature and the radiomic nomogram in the training cohort or the validation cohorts (all P>0.05). Conclusions: The nomogram provides a novel strategy for determining the Ki-67 PI in predicting the proliferation of subsolid nodules, which may be beneficial for the management of patients with SSNs.

Prediction of Higher Ki-67 Index in Pituitary Adenomas by Pre- and Intra-Operative Clinical Characteristics

Preoperatively Predicting Ki67 Expression in Pituitary Adenomas Using Deep Segmentation Network and Radiomics Analysis Based on Multiparameter MRI

Apparent Diffusion Coefficient Histogram Analysis for the Preoperative Evaluation of Ki-67 Expression in Pituitary Macroadenoma

Preoperative CT Histogram Analysis to Predict the Expression of Ki-67 in Solid Pseudopapillary Tumours of the Pancreas.

How Reliable is the Ki-67 Cytological Index in Grading Pancreatic Neuroendocrine Tumors? A Meta-Analysis

PUB034 Automated Quantification of Ki-67 Index Associates with Pathologic Grade and Prognosis of Pulmonary Neuroendocrine Tumors

Predictive Value of Preoperative MRI Features for the Ki-67 Index in Well-Differentiated G1/G2 Pancreatic Neuroendocrine Tumors.

Predicting the Ki-67 Proliferation Index in Pulmonary Adenocarcinoma Patients Presenting with Subsolid Nodules: Construction of a Nomogram Based on CT Images.

Preoperative Ki-67 Proliferation Index Prediction with a Radiomics Nomogram in Stage T1a-b Lung Adenocarcinoma

Clinicopathological Characteristics of Peripheral Clinical Stage IA Lung Adenocarcinoma with High Ki-67 Expression

Preoperative Prediction of Ki-67 Labeling Index by Three-dimensional CT Image Parameters for Differential Diagnosis of Ground-Glass Opacity (GGO)

Automated Quantification Of Ki-67 Index Associates With Pathologic Grade Of Pulmonary Neuroendocrine Tumors

Combined Utility of Ki-67 Index and Tumor Grade to Stratify Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Upfront Surgery

Prediction of the Recurrence of Non-Functioning Pituitary Adenomas Using Preoperative Supra-Intra Sellar Volume and Tumor-Carotid Distance

Relation of Proliferation and Apoptosis Indexes to the Invasiveness of Pituitary Adenomas

Mri-based Radiomics Signatures for Preoperative Prediction of Ki-67 Index in Primary Central Nervous System Lymphoma

Enhanced computed tomography features predict pancreatic neuroendocrine neoplasm with Ki-67 index less than 5%

Ki-67 Labeling Index May Be a Promising Indicator to Identify "very High-Risk" Gastrointestinal Stromal Tumor: a Multicenter Retrospective Study of 1022 Patients.

Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis

841P Ki67-revised Risk Index to Risk-Stratify Patients with Extra-Nodal Natural Killer/t Cell Lymphoma

P13.17.b predicting ki-67 proliferation index of meningiomas on mri: a deep learning method based on multi-modal information